| Top 2 Energy Stocks That Are Ticking Portfolio Bombs |
As of May 6, 2025, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. |
benzinga.com |
2025-05-06 12:20:08 |
Czytaj oryginał (ang.) |
| Why Frontline Stock Popped, but Exxon and ConocoPhillips Dropped |
Uh-oh. OPEC is up to something, and it's probably not good for oil stocks -- or more precisely, not good for all oil stocks. |
fool.com |
2025-05-05 15:04:48 |
Czytaj oryginał (ang.) |
| Verizon welcomes Ericsson to the ranks of “Verizon Frontline Verified” partners |
BASKING RIDGE, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Verizon Frontline today announced Ericsson Enterprise Wireless Solutions as the latest partner to earn “Verizon Frontline Verified” status. |
globenewswire.com |
2025-04-30 13:00:00 |
Czytaj oryginał (ang.) |
| Verizon Frontline Network Slice launches coast-to-coast |
Dedicated 5G UW network capacity for first responders strengthens communications for public safety Dedicated 5G UW network capacity for first responders strengthens communications for public safety |
globenewswire.com |
2025-04-24 14:00:00 |
Czytaj oryginał (ang.) |
| Verizon announces Rescue 42 as latest “Verizon Frontline Verified” partner |
BASKING RIDGE, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- Verizon Frontline today announced Rescue 42 as the latest partner to earn “Verizon Frontline Verified” status. |
globenewswire.com |
2025-04-17 13:00:00 |
Czytaj oryginał (ang.) |
| Zoom Workplace for Frontline now available to improve on-shift communications and work management for frontline workers |
SAN JOSE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Today, Zoom Communications, Inc. (NASDAQ: ZM), announced the launch of Zoom Workplace for Frontline, a purpose-built mobile-first solution that unlocks agentic Zoom AI Companion skills for all frontline workers and managers with paid Zoom accounts. |
globenewswire.com |
2025-04-16 13:00:00 |
Czytaj oryginał (ang.) |
| Is FRONTLINE PLC (FRO) Stock Outpacing Its Transportation Peers This Year? |
Here is how Frontline (FRO) and Grupo Aeroportuario del Centro Norte (OMAB) have performed compared to their sector so far this year. |
zacks.com |
2025-04-10 14:45:49 |
Czytaj oryginał (ang.) |
| Verizon's Frontline Solution Enhances Security in Mardi Gras Festival |
VZ provides critical unmanned aircraft systems to support the New Orleans Police Department during annual Mardi Gras celebrations. |
zacks.com |
2025-04-08 17:10:36 |
Czytaj oryginał (ang.) |
| Best Value Stocks to Buy for April 8th |
QFIN, NMRK and FRO made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 8, 2025. |
zacks.com |
2025-04-08 13:10:45 |
Czytaj oryginał (ang.) |
| New Strong Buy Stocks for April 8th |
FRO, BGC, NATL, QFIN and EME have been added to the Zacks Rank #1 (Strong Buy) List on April 8, 2025. |
zacks.com |
2025-04-08 11:15:34 |
Czytaj oryginał (ang.) |
| All You Need to Know About Frontline (FRO) Rating Upgrade to Strong Buy |
Frontline (FRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). |
zacks.com |
2025-04-04 17:05:44 |
Czytaj oryginał (ang.) |
| New Strong Buy Stocks for April 4th |
FRO, ESE, TKOMY, FUTU and SGHC have been added to the Zacks Rank #1 (Strong Buy) List on April 4, 2025. |
zacks.com |
2025-04-04 10:55:30 |
Czytaj oryginał (ang.) |
| Best Income Stocks to Buy for April 4th |
HSNGY, FRO and TEF made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 4, 2025. |
zacks.com |
2025-04-04 07:55:34 |
Czytaj oryginał (ang.) |
| Best Value Stocks to Buy for April 4th |
FRO, SCGLY and APTV made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 4, 2025. |
zacks.com |
2025-04-04 07:45:27 |
Czytaj oryginał (ang.) |
| Best Income Stocks to Buy for April 1st |
FRO, IX and UVSP made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 1, 2025. |
zacks.com |
2025-04-01 08:30:37 |
Czytaj oryginał (ang.) |
| Best Value Stocks to Buy for April 1st |
FRO, SAN and IX made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 1, 2025. |
zacks.com |
2025-04-01 08:20:33 |
Czytaj oryginał (ang.) |
| Should Value Investors Buy FRONTLINE PLC (FRO) Stock? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2025-03-31 14:41:25 |
Czytaj oryginał (ang.) |
| Are Investors Undervaluing FRONTLINE PLC (FRO) Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2025-03-14 12:45:36 |
Czytaj oryginał (ang.) |
| Actinium Pharmaceuticals Announces Initiation of Actimab-A Triplet Combination Frontline Trial Under NCI CRADA with Venetoclax and Taiho Oncology's Hypomethylating Agent ASTX-727 in Patients with Newly Diagnosed AML |
Represents first ever triplet combination using targeted radiotherapy as a backbone therapy in AML with initial clinical data expected in 2H:2025 Expansion into frontline setting greatly expands potential addressable patient opportunity for Actimab-A Triplet combination supported by previously completed Phase 1 trials of Actimab-A + Venetoclax and Actimab-A + CLAG-M demonstrating Actimab-A's mutation agnostic and synergistic potential NEW YORK , March 11, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced that the first clinical trial under its previously announced Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for Actimab-A has been initiated. The trial (NCT06802523) will evaluate the triplet combination comprised of Actimab-A, Venetoclax (Abbvie/Roche) an oral Bcl-2 inhibitor and ASTX-727 (Taiho Oncology, an Otsuka holdings company) a novel oral hypomethylating agent (HMA) in frontline acute myeloid leukemia (AML) patients. |
prnewswire.com |
2025-03-11 10:30:00 |
Czytaj oryginał (ang.) |
| 3 Shipping Stocks Worth Betting on Despite Industry Headwinds |
Following a careful analysis of the Zacks Transportation Shipping industry, we advise betting on stocks like FRO, FLNG and GOGL. |
zacks.com |
2025-03-10 13:11:11 |
Czytaj oryginał (ang.) |
| Analysts Estimate Frontline (FRO) to Report a Decline in Earnings: What to Look Out for |
Frontline (FRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-02-21 13:00:37 |
Czytaj oryginał (ang.) |
| Jefferies Loves 3 Very Large Crude Carriers That Pay Ultra-High-Yield Dividends Up to 12% |
Investors love dividend stocks, especially the ultra-high-yield variety because they offer a significant income stream and have massive total return potential. |
247wallst.com |
2025-02-20 15:47:57 |
Czytaj oryginał (ang.) |
| Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort |
Aptose Announces Positive Clinical Safety Review and Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib |
globenewswire.com |
2025-02-20 09:32:00 |
Czytaj oryginał (ang.) |
| 10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers |
Before January 31, 2025, my REaders mentioned 40 equities in their comments on my articles. Some bad-news investments (ROgues) mixed with (mostly) FAvorites. Thus, readers spoke-up about the ReFa/Ro. Ten analyst-target-estimated TOP-NET-GAIN ReFa/Ro: CAG, VZ, DOW, PFE, MRK GOGL, PK, PBR FRO, and TRMD averaged 40.36% net gains from reader data collected 2/17/25. Ten analysts target-augured January TOP-PRICE-UPSIDE reader faves & rogues (ReFa/Ro) were: CAG, VZ, PBR, DOW, PFE, GOGL, TRMD, PK, MRK, & FRO, boasting a 27.91% average target price upside estimate. |
seekingalpha.com |
2025-02-19 20:07:56 |
Czytaj oryginał (ang.) |
| Aptose's Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial |
TUS+VEN+AZA triplet achieves Cycle 1 complete remission (CR) in TP53-mutated/CK AML TUS+VEN+AZA triplet achieves Cycle 1 complete remissions in FLT3-wildtype AML patients TUS+VEN+AZA triplet shows favorable safety with no alteration of VEN and AZA dosing PK levels of TUS in the triplet remain equivalent to levels as TUS or TUS+VEN therapy SAN DIEGO and TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company, today reported promising early safety and response results from newly diagnosed acute myeloid leukemia (AML) patients dosed in Aptose's Phase 1/2 TUSCANY trial with a 40 mg dose of tuspetinib in combination with standard of care dosing of venetoclax and azacitidine (TUS+VEN+AZA triplet). The TUS+VEN+AZA triplet is being developed as a frontline therapy to treat large, mutationally diverse populations of newly diagnosed AML patients who are ineligible to receive induction chemotherapy. |
globenewswire.com |
2025-02-12 09:00:00 |
Czytaj oryginał (ang.) |
| 4 Contrarian Ultra-High-Yield Stocks Pay Huge Passive Income Dividends as High as 15% |
Passive income is characterized by its ability to generate revenue without requiring continuous active effort from the earner. |
247wallst.com |
2025-01-31 19:17:58 |
Czytaj oryginał (ang.) |
| Verizon Frontline delivering 5G connectivity to New York State Police cruisers |
ALBANY, N.Y., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Verizon Frontline today announced it will provide 5G connectivity across the New York State Police's fleet of vehicles through the activation of more than 1,800 lines of service. |
globenewswire.com |
2025-01-28 14:00:00 |
Czytaj oryginał (ang.) |
| Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial |
SAN DIEGO and TORONTO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company, today announced dosing the first set of patients in the TUSCANY Phase 1/2 study with tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA) as a frontline triple drug combination (triplet) therapy for patients newly diagnosed with acute myeloid leukemia, or AML. Tuspetinib based TUS+VEN+AZA triplet therapy is being advanced in the TUSCANY Phase 1/2 trial with the goal of creating an improved frontline therapy for newly diagnosed AML patients that is active across diverse AML populations, durable, and well tolerated. |
globenewswire.com |
2025-01-09 18:00:00 |
Czytaj oryginał (ang.) |
| New Body Camera by Motorola Solutions Boosts Safety for Frontline Workers |
CHICAGO--(BUSINESS WIRE)--Motorola Solutions (NYSE: MSI) today unveiled the V200, a body camera designed specifically to help protect frontline workers in stores, hospitals, hotels, schools and stadiums. Workers in these settings regularly face safety concerns – from unwelcome behavior to theft and medical emergencies – and the V200, with its GoLive Audio safety feature, offers a direct connection to help. The V200 body camera is a discreet, lightweight addition to a worker's uniform. The recor. |
businesswire.com |
2025-01-09 11:00:00 |
Czytaj oryginał (ang.) |
| 4 Of 35 Safe-Buy Dividend Power Dogs In January |
Four low-priced Dividend Power stocks, Golden Ocean, Invesco Mortgage, ARMOUR Residential, and FutureFuel, offer safer dividends with free cash-flow yields exceeding dividend yields. The Dividend Power strategy focuses on high earnings yield and top dividend yield stocks, creating a resilient portfolio for both downturns and bull markets. Analysts project significant gains for top Dividend Power stocks, with an average net gain of 79.97% on $10k invested in the top ten. |
seekingalpha.com |
2025-01-05 10:38:14 |
Czytaj oryginał (ang.) |
| Verizon Frontline showcases advanced communications solutions at EDGE25 |
The EDGE25 keynote will be delivered by Verizon Frontline and the U.S. Secret Service The EDGE25 keynote will be delivered by Verizon Frontline and the U.S. Secret Service |
globenewswire.com |
2025-01-02 11:00:00 |
Czytaj oryginał (ang.) |
| Is the Options Market Predicting a Spike in Frontline (FRO) Stock? |
Investors need to pay close attention to Frontline (FRO) stock based on the movements in the options market lately. |
zacks.com |
2024-12-30 11:25:29 |
Czytaj oryginał (ang.) |
| 5 Ultra-High-Yield Dividend Stocks for 2025 Wall Street Is Pounding the Table On |
Dividend stocks are a favorite among investors for good reason. They provide a steady income stream of passive income and offer a promising avenue for total return. |
247wallst.com |
2024-12-24 11:11:46 |
Czytaj oryginał (ang.) |
| Verizon Frontline powers NORAD Tracks Santa initiative for 22nd year |
Enhanced network solutions and Verizon Frontline assets provide redundancy and reliability so children around the world can track Santa Enhanced network solutions and Verizon Frontline assets provide redundancy and reliability so children around the world can track Santa |
globenewswire.com |
2024-12-19 16:00:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for November 19th |
FRO, DHT and CVE have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2024. |
zacks.com |
2024-12-19 09:26:07 |
Czytaj oryginał (ang.) |
| Verizon Frontline Crisis Response Team supports 800+ agencies during 2024 emergency responses |
What you need to know: The Verizon Frontline Crisis Response Team deployed nearly 900 times in 2024, supporting first responders in nearly every state and Washington D.C. The team responded to requests for support from public safety agencies during responses to tornadoes, hurricanes, and wildfires. |
globenewswire.com |
2024-12-18 17:00:00 |
Czytaj oryginał (ang.) |
| 100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial |
Two of three patients achieved both complete remission and MRD-negative status High response rates observed in earlier studies continue in ongoing mipletamig trial Cohort 2 enrollment commencing SEATTLE, WA / ACCESSWIRE / December 12, 2024 / Aptevo Therapeutics ("Aptevo") (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel bispecific immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced 100% of patients achieved remission* within 30 days, in Cohort 1 of the RAINIER frontline acute myeloid leukemia (AML) Phase 1b trial, including two patients who experienced complete remission with minimal residual disease (MRD)-negative status (100% elimination of cancer cells). The results build on data from the prior trial, in which 100% of frontline patients also achieved remission. |
accesswire.com |
2024-12-12 11:00:00 |
Czytaj oryginał (ang.) |
| Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision |
DALLAS, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care, today announced the completion of enhancements to its technical file to support significant software updates for its DeepView SnapShot® M and DeepView AI-Burn® system in the UK. These upgrades, informed by real-world experience and frontline feedback from clinicians, are designed to enhance product performance and usability in the UK, further solidifying the Company's commitment to delivering and commercializing cutting-edge solutions in critical care settings. |
globenewswire.com |
2024-12-09 10:00:00 |
Czytaj oryginał (ang.) |
| Syndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial |
– Subgroup analyses from Ph 2 protocol-defined R/R mNPM1 AML efficacy population (N=64) show responses across all major subgroups, including heavily pretreated patients – – 26% CR+CRh (20/77) and 48% ORR (37/77) in all enrolled patients who met the efficacy evaluable criteria in Ph 2 R/R mNPM1 AML cohort – – 100% ORR (37/37) and 95% CRc (35/37) in BEAT AML trial exploring revumenib in combination with venetoclax/azacitidine in newly diagnosed mNPM1 or KMT2Ar AML – – BEAT AML data highlight the potential for revumenib to advance the current standard of care – WALTHAM, Mass. , Dec. 9, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced additional positive data from the AUGMENT-101 trial of Revuforj® (revumenib) in relapsed or refractory (R/R) mutant NPM1 (mNPM1) acute myeloid leukemia (AML) and the BEAT AML trial of revumenib in combination with venetoclax and azacitidine in newly diagnosed AML patients. |
prnewswire.com |
2024-12-09 09:30:00 |
Czytaj oryginał (ang.) |
| Frontline Stock Drops On Q3 2024 Earnings Report Amidst Tanker Market Uncertainty |
Frontline stock hit a 52-week low this week after Q3 2024 earnings. The maritime oil shipping sector is experiencing volatility and uncertainty. Frontline's Q3 earnings were in line and showed YoY growth, but spot contract prices are decreasing. |
seekingalpha.com |
2024-12-03 10:30:00 |
Czytaj oryginał (ang.) |
| Is the Options Market Predicting a Spike in Frontline (FRO) Stock? |
Investors need to pay close attention to Frontline (FRO) stock based on the movements in the options market lately. |
zacks.com |
2024-11-29 11:10:16 |
Czytaj oryginał (ang.) |
| Frontline plc (FRO) Q3 2024 Earnings Call Transcript |
Frontline plc (FRO) Q3 2024 Earnings Call Transcript |
seekingalpha.com |
2024-11-27 14:36:27 |
Czytaj oryginał (ang.) |
| Verizon Frontline delivers critical connectivity during U.S. Capitol Christmas Tree Harvest |
What you need to know: The Verizon Frontline Crisis Response Team supported the U.S. Forest Service with multiple mission-critical communications solutions during the harvest of the U.S. Capitol Christmas Tree near Wrangell, Alaska Advanced communication technologies will assist the crew transporting the tree across the continent from Alaska to Washington, D.C. WRANGELL, Alaska, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Verizon Frontline Crisis Response Team recently completed a deployment in support of the U.S. Forest Service and other organizations during the harvest of the 2024 U.S. Capitol Christmas Tree. |
globenewswire.com |
2024-11-26 11:00:00 |
Czytaj oryginał (ang.) |
| At 12% Yield, Frontline Is A No-Brainer Investment |
Frontline plc offers a high dividend yield of 12%, but has a history of unpredictable dividend cuts, making it suitable for aggressive investors. Despite geopolitical risks, oil prices are expected to stay above $70/barrel, benefiting midstream companies like FRO, which are crucial for oil transport. Earnings estimates for FRO are positive, with expected 25% YoY revenue growth, but the company has a history of disappointing earnings reports. |
seekingalpha.com |
2024-11-26 00:55:00 |
Czytaj oryginał (ang.) |
| Verizon announces Dejero as latest “Verizon Frontline Verified” partner |
BASKING RIDGE, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Verizon Frontline today announced Dejero as the latest partner to earn “Verizon Frontline Verified” status. |
globenewswire.com |
2024-11-19 11:00:00 |
Czytaj oryginał (ang.) |
| Verizon Frontline delivers connectivity during North Carolina nuclear incident training exercise |
What you need to know: The Verizon Frontline Crisis Response Team supported first responders participating in the exercise Advanced communication technologies helped ensure seamless coordination across jurisdictions and organizations Verizon provided multiple mission-critical communications solutions SOUTHPORT, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Verizon Frontline Crisis Response Team recently completed a deployment in support of first responders participating in a Nuclear Hostile Action Exercise in Brunswick County, North Carolina. |
globenewswire.com |
2024-11-12 11:10:00 |
Czytaj oryginał (ang.) |
| HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 |
Society of Immunotherapy of Cancer (SITC) poster to be presented by collaborator from Memorial Sloan Kettering Cancer Center, Dr. Alan Ho, on November 9, 2024 Society of Immunotherapy of Cancer (SITC) poster to be presented by collaborator from Memorial Sloan Kettering Cancer Center, Dr. Alan Ho, on November 9, 2024 |
globenewswire.com |
2024-10-31 11:17:00 |
Czytaj oryginał (ang.) |
| Frontline Education Partners with Equifax® to Bring The Work Number® to ERP Clients in Texas and California |
Wayne, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Frontline Education, a leading provider of administration software purpose-built for educators in K-12, today announced a new partnership with Equifax®, a global data, analytics, and technology company, to offer The Work Number®, a robust income and employment verification service, to its Enterprise Resource Planning (ERP) clients in Texas and California. |
globenewswire.com |
2024-10-22 12:12:00 |
Czytaj oryginał (ang.) |
| Top Income Stocks Offering Big Dividend Yields and Future Growth |
Combining growth and income can be extremely valuable when investing in the stock market. While dividends can provide a stable and consistent stream of cash, the potential for growth can lead to capital appreciation. |
marketbeat.com |
2024-10-10 13:12:12 |
Czytaj oryginał (ang.) |
| Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer |
--Encouraging progression-free survival data in overall population; continued follow-up needed to allow data to mature further, especially in low ctDNA subgroup where events accrue more slowly |
globenewswire.com |
2024-09-30 20:05:00 |
Czytaj oryginał (ang.) |